Inify Laboratories Reports Growing NHS Interest in the UK
Inify Laboratories says it is gaining traction in the UK, citing growing NHS interest and data on diagnostic quality.
Related stories
Shadowfax Q2 Profit Rises to ₹68 Crore as Revenue Grows 57%
Shadowfax Technologies reported net profit of ₹68 crore for the September quarter, up from ₹13 crore a year earlier. Revenue grew 57% year on year.
M impact | EQUITY | Oct 29, 2026, 09:16 AM UTC
Beijing Capital Development Reports Q3 Net Loss of 1.1 Billion Yuan
M impact | EQUITY | Oct 29, 2026, 09:16 AM UTC
Apar Industries Shares Gain 5% After Q2 Profit and EBITDA Beat Estimates
Apar Industries reported second-quarter profit after tax of ₹447 crore, versus a CNBC-TV18 poll estimate of ₹339 crore and ₹51.7 crore a year earlier. Shares gained 5%, and margins
M impact | EQUITY | Oct 29, 2026, 09:16 AM UTC
Senores Pharmaceuticals Shares Fall 3% as Q2 Profit Rises 22%, Revenue 25%
Senores Pharmaceuticals shares fell 3% despite increases in quarterly profit and revenue. The body says results were for the quarter ended in September 2026.
M impact | EQUITY | Oct 29, 2026, 09:16 AM UTC
Dashenlin Pharmaceutical Q3 Net Profit Rises 21.7% Y/Y
M impact | EQUITY | Oct 29, 2026, 09:16 AM UTC
Haleon CEO Says China Centrum OTC Issue May Persist Through 2027
Haleon is working to mitigate the China Centrum OTC issue through portfolio changes in China.
L impact | EQUITY | Oct 29, 2026, 09:16 AM UTC